Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5605213 | International Journal of Cardiology | 2017 | 9 Pages |
Abstract
Activated HAT activity of p300 modulates AV calcification through osteogenic transdifferentiation of VICs with Klotho modulation. P300 inhibition is a potential therapeutic target for AV calcification.
Keywords
TGFTNFHigh phosphateTNAPCAVDretinoid-X receptorRXRVDREVDREGR-1ECMP300IκBNF-κBMMPVICHDACERKMAPKOsteogenesiscalcific aortic valve diseasetransforming growth factorAortic valveValve interstitial cellValvular interstitial cellsvitamin D response elementtumor necrosis factornuclear factor kappa-light-chain-enhancer of activated B cellsPhosphateExtracellular matrixmatrix metalloproteinaseinhibitor of kappa BHistone acetyltransferasehistone deacetylaseearly growth response-1mitogen-activated protein kinaseHATAortic valve calcificationKlothoextracellular signal-regulated kinase
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shao-Jung Li, Yu-Hsun Kao, Cheng-Chih Chung, Wei-Yu Chen, Wan-li Cheng, Yi-Jen Chen,